Tag: pmi

  • FDA authorizes 11 additional ZYN nicotine pouches

    FDA authorizes 11 additional ZYN nicotine pouches

    Today (Aug. 21), the U.S. Food and Drug Administration authorized 11 new nicotine pouch products from Swedish Match USA under the Zyn Ultra brand through the premarket tobacco product application pathway. The products include 10 9-milligram varieties and one 11-milligram variety, covering flavors such as Chill, Citrus, Cool Mint, Deep Freeze, Menthol, Peppermint, Smooth, Spearmint, and Wintergreen.

    The FDA said its review found the products contain lower levels of most harmful and potentially harmful constituents than other oral and smokeless tobacco products. The agency also said product-specific data indicated the pouches appeal primarily to adults who currently smoke cigarettes or use smokeless tobacco and could provide sufficient nicotine to reduce cravings and withdrawal symptoms, potentially supporting switching among adult tobacco users.

    “We are delighted with the FDA’s decision to authorize a range of ZYN ULTRA products, which will build on ZYN’s position as America’s leading smoke-free product brand,” said Stacey Kennedy, PMI U.S. CEO. “We look forward to expanding our portfolio of better choices for the 45 million Americans who consume nicotine products.” 

    The authorizations bring the number of FDA-authorized nicotine pouch products to 43, including 23 approved through the agency’s nicotine pouch pilot program. The FDA said the pilot has streamlined PMTA reviews and reduced the time needed to resolve deficiencies, with efficiencies now being applied to other tobacco-product applications.

  • PMI to Launch VEEV E-Vapor Product in South Korea

    PMI to Launch VEEV E-Vapor Product in South Korea

    Philip Morris Korea announced that it will launch its VEEV e-vapor product in South Korea on Aug. 26 as the company expands its smoke-free portfolio in the country. KT&G currently leads South Korea’s non-combustible tobacco segment with a 48% market share, followed by Philip Morris and British American Tobacco.

    Philip Morris International said 42% of its $11 billion in second-quarter revenue came from smoke-free products. The company has invested 22.5 trillion won ($16 billion) in research and development for smoke-free products since 2008 and is targeting a two-thirds share of sales from smoke-free products by 2030.

    PMI Korea consumer experience director Kim Tae-hyung said the company ultimately aims to replace combustible cigarettes with smoke-free products.

  • PMI Launches Airport-Exclusive IQOS

    PMI Launches Airport-Exclusive IQOS

    Philip Morris International launched a limited-edition IQOS ILUMA i Prime Skylens, its first device created exclusively for airport travel retail. Inspired by aviation and the “above the clouds” experience, the premium device features a metallic blue design and is being introduced through activations at selected duty-free locations.

    The launch debuted at Tokyo’s Narita International Airport with a pop-up featuring product discovery, augmented reality, and a lounge-style environment. PMI has since expanded Skylens to selected airports across Europe, including Germany, Italy, Spain, Greece, Switzerland, and Serbia, as well as South Korea, Qatar, Saudi Arabia, Egypt, Morocco, Lebanon, and Malaysia.

    Beste Ermaner, PMI’s vice president of global travel retail, said the initiative is designed to make smoke-free products more accessible to adult smokers in travel environments. PMI said IQOS is used by more than 35 million adults worldwide who would otherwise continue to smoke.

  • Reuters: Nicotine Pouches Emerge as Big Tobacco’s Key Growth Bet

    Reuters: Nicotine Pouches Emerge as Big Tobacco’s Key Growth Bet

    Reuters reports that nicotine pouches are attracting increasing investor attention as cigarette sales decline, with rapid volume growth, strong margins and relatively light regulation in many markets making brands such as PMI’s Zyn and BAT’s Velo a major focus for tobacco companies. BAT expects the global pouch market to grow from £4 billion in 2025 to £11 billion by 2030, while pouch volumes in its Asia, Middle East and Africa markets increased 27.5% to about 700 million in the first half of 2026.

    Reuters said the category also offers higher profitability than several competing alternatives. PMI reported that its U.S. oral nicotine business generated eight times the gross profit per 1,000 units of its international cigarette business in 2024, compared with 2.4 times for IQOS heated tobacco. Analysts said pouch performance is increasingly influencing tobacco-company valuations, while the products’ lack of smoke or vapor allows them to be used in locations where other nicotine products may be restricted.

    The story noted that wider adoption remains uncertain, particularly in markets without an established oral nicotine culture. Analysts cited consumer familiarity with inhaled products as a key barrier, while regulators are increasingly scrutinizing youth uptake, marketing and high nicotine strengths. France has banned pouches, while Finland, the EU and Britain are tightening rules. Despite expectations for continued growth, PMI and BAT say no single alternative will replace cigarettes, with diverse portfolios needed to accommodate different consumer preferences.

  • A Needed Course Correction on Tax Stamping—And a Blueprint for Other States

    A Needed Course Correction on Tax Stamping—And a Blueprint for Other States

    By Dan Mulvaney, PMI U.S.

    For decades, tax stamping has been a cornerstone of most state excise tax systems for cigarettes. The stamping works, in part, because of the per unit tax and packs of cigarettes are uniform in size and distribution. By requiring wholesalers to purchase and affix tax stamps before products reach retail, states have created an efficient, centralized model for tax collection—one that depends on the wholesale channel to function effectively.

    What is often overlooked is the role wholesalers actually play. They are not passive participants—they are, in effect, the state’s tax collection agents. They purchase stamps, invest in specialized equipment, manage inventory controls, and maintain strict compliance and reporting protocols. This is not theoretical; it is an operational reality requiring significant time, labor, and capital.

    That is why stamping allowances have historically existed: to offset the cost of collecting and remitting excise taxes on behalf of the state.

    Yet in recent years, policymakers have moved in the wrong direction. Across the country, stamping allowances have come under pressure—often viewed as a revenue opportunity rather than compensation for a mandated service. In some cases, policymakers have even considered eliminating them altogether, disregarding the real costs imposed on wholesalers.

    Fortunately, the Louisiana Legislature understands the importance of stamping allowances and  what a modern, risk-aligned tax framework should look like. The state has reduced the excise tax rate by 65% for certain products that meet the high bar of being an FDA-authorized Modified Risk Tobacco Product (MRTP). Currently, two unique products – Philip Morris International’s (PMI’s) heated tobacco product, IQOS, and 22nd Century Group’s low nicotine cigarette, VLN – have received this designation, recognizing their distinct profile from traditional cigarettes.

    Just as important, Louisiana paired this approach with practical supply chain incentives. Wholesalers will receive a 10% discount on MRTP tax stamps, while the existing cigarette stamp discount increases from 5% to 6.5%. This preserves operational stability while creating a clear differential that favors modified-risk alternatives.

    Together, these changes reinforce the right market signals—supporting state revenue, maintaining system integrity, and accelerating the transition from traditional cigarettes to modified-risk alternatives.

    By increasing the cigarette stamping allowance, policymakers have taken an important step toward restoring balance—acknowledging that the system only works when the entities responsible for executing it are properly supported.

    This outcome did not happen in a vacuum. It reflects sustained engagement by manufacturers, such as PMI, to ensure that wholesalers and retailers have a voice in the policymaking process. At a time when many stakeholders remain focused solely on tax rates or product restrictions, PMI has consistently focused on the operational realities facing the trade.

    More importantly, PMI has demonstrated leadership as a true partner to the wholesale and retail community. This new law is a clear example of that commitment translating into tangible economic value.

    This is more than a policy update. It is a recognition of the essential role wholesalers play in maintaining efficient, compliant tax systems—and proof that collaboration between policymakers and industry can deliver better outcomes.

    In an environment where allowances have too often been reduced or overlooked, this represents a meaningful course correction. It strengthens the supply chain, supports compliance, and reinforces a simple truth: when policymakers and industry partners work together—and when manufacturers are willing to lead—the entire system benefits.

    Dan Mulvaney is director of industry engagement for Philip Morris International Inc. (PMI) U.S. The businesses of PMI U.S. are on a mission to improve public health in America by providing the roughly 30 million legal-age consumers who still smoke traditional cigarettes with better, smokefree alternatives. PMI U.S. is committed to responsible marketing practices that help prevent access to its products by people under the age of 21. 

  • PM Korea to Launch VEEV E-Cigarette

    PM Korea to Launch VEEV E-Cigarette

    Philip Morris Korea will launch its VEEV inPRIME liquid e-cigarette on Aug. 18 as part of Philip Morris International’s expansion of its non-combustion portfolio. The closed-pod system uses a rechargeable device and replaceable pods, with five device colors and five pod varieties. Pre-sales begin Aug. 11 at IQOS flagship stores, with broader retail distribution from Aug. 26.

    The VEEV inPRIME device will retail for 29,000 won ($20.60), while 2ml VEEBI inPRIME pods will cost 8,000 won ($5.68). Philip Morris Korea said the launch expands choices for adult smokers and represents the company’s broader multi-category strategy in South Korea.

  • Dutch Regulator Rules on PMI’s EU Consultation Campaign

    Dutch Regulator Rules on PMI’s EU Consultation Campaign

    The Netherlands’ advertising standards watchdog, the Reclame Code Commissie (RCC), found that a Philip Morris campaign encouraging public input into the EU’s tobacco-rules review fell within the scope of the country’s tobacco advertising ban.  The campaign invited people to submit comments to the European Commission opposing tighter EU rules on tobacco and nicotine products. An investigation by NOS and Pointer reported that Philip Morris used an AI tool to generate hundreds of responses presented as individual citizens’ views.

    The RCC said the campaign had a commercial character because the AI text generator was developed and paid for by Philip Morris, and that the generated responses portrayed alternative tobacco products positively. The watchdog concluded that presenting the activity as public consultation did not remove it from the scope of the advertising ban. Doctors and health organizations had filed a complaint over the campaign in June, while Philip Morris said it was contributing to the public debate.

  • Decision Nears in Brazil’s Tobacco Health-Cost Lawsuit

    Decision Nears in Brazil’s Tobacco Health-Cost Lawsuit

    A landmark lawsuit filed by Brazil’s Office of the Attorney General in 2019 seeking to recover public healthcare costs linked to smoking has reached the decision stage. All legal submissions have been completed, including an opinion from the Federal Public Prosecutor’s Office supporting the government’s claims. The Federal Court in Porto Alegre will now decide whether the country’s largest cigarette manufacturers are liable for health damages associated with the marketing and sale of their products.

    The case targets BAT Brazil and Philip Morris Brazil, and their parent companies, British American Tobacco and Philip Morris International, seeking compensation for tobacco-related healthcare expenditures. The lawsuit estimates that smoking causes about 177,000 deaths annually in Brazil and R$75 billion ($15 billion) in healthcare costs.

  • Philip Morris Italia Launches €1 Million Academy for Tobacconists

    Philip Morris Italia Launches €1 Million Academy for Tobacconists

    Philip Morris Italia announced the launch of the Trade Academy, a €1 million training initiative developed with the Italian Tobacconists Federation (FIT) to support the professional development of approximately 45,000 tobacconists across Italy. The program offers digital and in-person training in areas such as leadership, business management, and public speaking, as well as university scholarships and professional development opportunities for retailers and their families.

    The Trade Academy will run through the end of 2026 and is part of Philip Morris International’s broader investment in its Italian supply chain. The company said the initiative is designed to strengthen retailer competitiveness, improve customer engagement and build skills across its commercial network as part of its long-term investment in human capital.

  • PMI U.S. Opens $1.2 Billion Colorado Manufacturing Campus

    PMI U.S. Opens $1.2 Billion Colorado Manufacturing Campus

    Philip Morris International’s U.S. businesses announced the official opening of its $1.2 billion manufacturing campus in Aurora, Colorado, expanding domestic production capacity for Zyn nicotine pouches and strengthening the company’s U.S. supply chain and export capabilities. The 780,000-square-foot facility, located on a 148-acre site, began full commercial production in July 2026 and represents PMI U.S.’s first greenfield manufacturing complex in the United States. The campus integrates production, packaging, warehousing, distribution, and operations, and will support markets across Asia, Latin America, and the Caribbean.

    The investment, originally announced as a $600 million project in 2024, doubled in planned capital expenditures through 2028, including manufacturing equipment, infrastructure, facility development, and future production expansion. “Aurora represents an important milestone for PMI U.S. and our continued investment in our business here,” said Stacey Kennedy, CEO of PMI U.S. “This facility expands our production capacity, strengthens our supply chain, and enhances our ability to serve growing demand in the United States and around the world.”

    The facility is expected to directly employ approximately 500 people and contribute to broader economic activity in Colorado, with PMI estimating the site will support around 1,000 indirect jobs.